Sunflower Pharmaceutical Group Co.,Ltd

Informe acción SZSE:002737

Capitalización de mercado: CN¥11.8b

Sunflower Pharmaceutical GroupLtd Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Yi Guan

Chief Executive Officer (CEO)

CN¥4.8m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO5.8yrs
Participación del CEOn/a
Permanencia media de la dirección2.9yrs
Promedio de permanencia en la Junta Directiva3.4yrs

Actualizaciones recientes de la dirección

Recent updates

We Believe That Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Weak Earnings Are A Good Indicator Of Underlying Profitability

Nov 04
We Believe That Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Weak Earnings Are A Good Indicator Of Underlying Profitability

A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)

Aug 26
A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)

Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E

Jul 19
Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E

Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 07
Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

Apr 16
Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

Mar 04
We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

CEO

Yi Guan (42 yo)

5.8yrs

Permanencia

CN¥4,800,000

Compensación

Ms. Yi Guan has been a Non-Independent Director of Sunflower Pharmaceutical Group Co., Ltd. since September 26, 2017 and serves as its General Manager since January 07, 2019. She was awarded the title of H...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Yi Guan
GM & Non-Independent Director5.8yrsCN¥4.80msin datos
Chunhong Wu
Financial Manager2.9yrsCN¥774.90ksin datos
Guangguang Zhou
Board Secretary2.8yrsCN¥436.70ksin datos
Liang Chen
Deputy General Manager2.9yrsCN¥3.06msin datos
Jin Ming Lin
Deputy General Manager4.8yrsCN¥786.00ksin datos
Xin Ma
Deputy General Manager2.9yrsCN¥1.36msin datos
Yang Hai
Deputy General Manager2.9yrsCN¥1.41msin datos

2.9yrs

Permanencia media

43yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 002737 se considera experimentado (2.9 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Yi Guan
GM & Non-Independent Director7.2yrsCN¥4.80msin datos
Yanling Guan
Non-Independent Director10.7yrsCN¥1.18msin datos
Jingshang Ren
Non-Independent Director7.2yrsCN¥50.00ksin datos
Yan He
Non-Employee Supervisor7.2yrssin datossin datos
Chunyan Na
Supervisor4.1yrssin datossin datos
Yuxiu Guan
Chairman5.8yrsCN¥1.20msin datos
Fen Lan
Chairman of the Supervisory Board2.7yrssin datossin datos
Jianzhong Zhou
Non-Independent Directorless than a yearsin datossin datos
Yang Yang
Non-Independent Directorless than a yearsin datossin datos
Jiajun Miao
Independent Directorless than a yearsin datossin datos
Ying Zhang
Independent Directorless than a yearsin datossin datos
Yan Zhao
Independent directorless than a yearsin datossin datos

3.4yrs

Permanencia media

46yo

Promedio de edad

Junta con experiencia: La junta directiva de 002737 se considera experimentada (3.4 años de antigüedad promedio).